Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02900040

Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation

The French DIVAT (standing for Données Informatisées et VAlidées en Transplantation in french, and in English "Computerized and VAlidated Data in Transplantation" ) cohort was Kicked off in 1994 by the Transplantation Urology Nephrology Institute of the Nantes University Hospital in France. The primary objective of this multicenter computerized database was to enable prospective clinical and epidemiological research studies concerning kidney transplant recipients, particularly focusing on mid- and long-term clinical outcomes, therapeutic strategies and public health issues. The patient-case system of the DIVAT cohort allows the monitoring of medical records of all patient-specific and allograft-specific data, including bio-banking since 2005. Data are collected from the date of transplantation until the graft failure, at each scheduled outpatient visit or hospital admission motivating by a new clinical, therapeutical or biological expression. The DIVAT cohort contains information on more than 11000 transplant recipients between 1994 and today, issued from 8 French university hospitals centers (the DIVAT Network is organized by a consortium agreement). 18% of all patients underwent retransplantation and 11% of all kidney transplants originated from living donors. The DIVAT network heavily works to ensure a high-quality data collection with the aim of exploring adequately the complex post-transplantation process. The Divat network encourage collaborations and enables interested researchers to submit a research project by completing a request form available on the DIVAT website (http://www.divat.fr/en) describing the context, objectives and design of the study

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Docteur Buron, Lyon, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • over the age of 18 years
  • with renal transplant

Exclusion criteria

  • minor
  • pediatric transplantation

Treatment and study plan

Kidney Transplantation

Other

Primary outcomes

  1. Proportion of participants with Overall Survival

    Time frame: 2 years

  2. Proportion of participants with Overall Survival

    Time frame: 4 years

  3. Proportion of participants with Overall Survival

    Time frame: 6 years

Secondary outcomes

  1. expansion of effector memory CD8+ T cells dosage

    Time frame: 1 year

    potential marker for acute graft dysfunction

  2. expansion of effector memory CD8+ T cells dosage

    Time frame: 6 years

    potential marker for late graft dysfunction

Study contacts

Contact information is provided by the study sponsor or research team.

Magali Giral, PU-PH

CONTACT

[email protected]

+33 (0)2 40 08 74 43

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Official study title

The French DIVAT: a Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation

Acronym: DIVAT

Important dates

Study start
1994
Primary completion
2050
Study completion
2050
First posted
Sep 14, 2016
Registry last updated
Sep 15, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.